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An increasing body of evidence suggests that apoptosis of structural cells in the lung might be an important upstream event in the 
pathogenesis of chronic obstructive pulmonary disease (COPD). AP-2α is one of the important transcription factors involved in 
the modulation of apoptosis in carcinogenesis and idiopathic-dilated cardiomyopathy. The relationship between AP-2α and apop-
tosis in COPD remains to be elucidated. The aim of the present study was to investigate the expression of AP-2α in the lung tis-
sues of rats with COPD induced by smoking and its possible protective effect on cigarette smoke extract (CSE) induced endothe-
lial cell apoptosis. Sprague-Dawley rats (n = 24) were randomly assigned to normal and COPD groups. The COPD group was 
exposed to smoke from 20 commercial unfiltered cigarettes for 80 d before morphological assessment of the lung tissue was per-
formed. The expression of AP-2α in lung tissues was measured by Western blotting. To demonstrate the relationship between 
apoptosis and AP-2α, in vitro cell experiments were carried out. Cells were treated with different concentrations of CSE before 
proliferation was measured by MTT. Apoptosis was then determined by Hoechst staining and the expression of cleaved caspase-3 
and AP-2α by Western blotting over time following treatment with 5% CSE. Cells were then infected with an AP-2α adenovirus 
vector and the expression of cleaved caspase-3 and AP-2α was compared to the control groups by Western blotting. The COPD 
group showed larger air spaces and significant decrease of FEV0.3/FVC compared with the rats in the control group (P<0.05). The 
expression of AP-2α was significantly higher in the lung tissue of rats with COPD compared with those of controls (P<0.05). In 
the ECV304 cells, CSE induced apoptosis (P<0.01) and caspase-3 activation in a time-dependent manner and reduced the cell 
proliferation rate in a dose-dependent manner (P<0.005). Moreover, 5% CSE treatment increased endogenous AP-2α protein 
expression. AP-2α overexpression inhibited 5% CSE-induced cell apoptosis and activated caspase-3 expression (P<0.05) AP-2α 
protects ECV304 cells against CSE-induced apoptosis and may play an important role in smoking induced-apoptosis in COPD. 
AP-2α, apoptosis, cigarette smoke extract, COPD, vascular endothelial cell 
 
Citation:  Li J L, Chen Y, Chen P, et al. AP-2α expression and cell apoptosis of the lung tissue of rats with COPD and ECV304 cells stimulated by cigarette smoke 




Chronic obstructive pulmonary disease (COPD) is one of 
the major public health problems because of its high mor-
bidity and mortality, but its pathogenesis remains enigmatic. 
Cigarette smoking is one of the major etiological factors of 
COPD, with the mechanisms including chronic inflamma-
tion [1], elastase/antielastase imbalance [2] and oxidant/ 
antioxidant imbalances [3]. Recently, more and more studies 
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have shown increased apoptosis in the alveolar walls in 
COPD patients [4] and COPD animal models [5] induced 
by cigarette smoke exposure. Some studies related apoptosis 
in alveolar walls to emphysema in animal models. The 
pro-apoptosis mechanisms of cigarette smoke exposure 
were related to activated caspase [6], decreases in VEGF 
and VEGFR-2 [7], increased oxidative stress [8], inflamma-
tion and impaired repair responses [9].  
Activator protein-2 (AP-2) is a family of cell type-specific 
and developmentally regulated transcription factors. To date, 
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five members of the AP-2 family including AP-2α, AP-2β, 
AP-2γ, AP-2δ and AP-2ε have been identified. AP-2α has been 
implicated in vertebrate development, embryogenesis [10], car-
cinogenesis [11] and idiopathic-dilated cardiomyopathy [12]. 
As a transcription factor, AP-2α was suggested to associate 
with apoptosis by modulating the expressions of many genes 
such as VEGF [13], P53 [14], p21WAF/CIP [15], Bcl-2 [16] and 
manganese superoxide dismutase (MnSOD) [17]. 
Based on the important status of apoptosis in COPD and 
that AP-2α is involved in apoptosis in many diseases, in this 
study we investigated the expression of AP-2α in the lung 
tissue of smoking-induced COPD rats as well as the effect 
of AP-2α over-expression in the CSE-induced apopotosis of 
ECV304 cells.  
1  Materials and methods 
1.1  Animals 
Twenty-four male Sprague-Dawley rats, each weighing 
186–240 g, were purchased from the Animal Center of the 
Second Xiangya Hospital, Changsha, China. The rats were 
randomly assigned to two groups of 12: normal control and 
COPD groups. The COPD group was exposed to smoke 
from 20 commercial unfiltered cigarettes (Furong, Changde 
Cigarette Factory, Changde, Hunan, China) for 1 h each 
day, 6 d a week, for a total of 80 d. The smoke exposure box 
was 69 cm×47 cm×38 cm. The control group were treated 
the same as the COPD group except with the absence of 
smoke exposure. Experiments were approved by the animal 
ethics committee and were performed following strict gov-
ernment and international guidelines. 
1.2  Morphological assessment 
After fixation, 5-μm lung sections were stained with hema-
toxylin and eosin (HE) stain. As emphysema is a structural 
disorder characterized by destruction of the alveolar walls 
and enlargement of the alveolar spaces, enlargement of al-
veolar spaces was assessed by quantifying the mean linear 
intercept (MLI) and destruction of alveolar walls by meas-
uring the destructive index (DI) [18]. MLI, a measure of 
inter-alveolar wall distance, was determined by light mi-
croscopy at a magnification of 100×. Fields that included 
large airways or vessels were excluded from the analysis. 
MLI was defined as the total length of the cross-line divided 
by the numbers of alveolar walls intersecting the test lines, 
as described by Xu et al. [19]. DI was calculated as a meas-
ure of parenchymal destruction using a microscopic point-
count technique [20]. The analysis was performed in dupli-
cate by randomly counting more than 3000 alveoli from 50 
HE sections from each rat at a magnification of 200×. For 
each photomicrograph, a single observer who was blind to 
the related data performed the measurements. 
1.3  Pulmonary function 
Half of the rats from the two groups were randomly selected 
for lung function measurements, according to the method 
described by Chen et al [21]. After induction of anaesthesia 
by intraperitoneal administration of chloral hydrate (3 
mL/kg), a Y-type endotracheal cannula was connected to a 
flow transducer (HX200, Beijing Xinghangxingye Corpora-
tion, Beijing, China) for measurement of FEV0.3/FVC 
(Forced expiratory volume in 0.3 s/Forced vital capacity) 
and PEF (Peak expiratory flow). 
1.4  Cell culture 
ECV304 cells obtained from the Xiangya Type Culture 
Collection (Changsha, China), were cultured in RPMI me-
dium 1640 supplemented with 10% heat-inactivated new-
born bovine serum and antibiotic-antimycotic mix in a hu-
midified incubator with 5% CO2 and 95% air. At 70%–80% 
confluence, ECV304 cells were treated with CSE and/or 
adenovirus infection. 
1.5  Preparation of cigarette smoke extract (CSE) 
CSE was generated by bubbling smoke from 1 standard 
reference cigarette into 20 mL RPMI medium 1640 (Life 
Technologies, California, USA) through a 50-mL fritted 
impinger at a flow rate of 350 mL/min. The resulting extract 
was passed through a 0.22-μm filter and was considered 
100% CSE. The CSE was adjusted to pH 7.4 by the addition 
of NaOH before being diluted to 2.5%–20% concentration 
with RPMI medium 1640 and used within 1 h. 
1.6  Adenovirus reagents and infections 
The Ad-AP-2α adenovirus vector and its control Ad-BgII 
were generously provided by Dr F. Domann of Iowa Uni-
versity (USA). Adenoviral infections were carried out as 
described [22]. Briefly, 5 × 105 cells were plated in a 60-mm 
culture dish. After 24 h of culture, when reaching 80% con-
fluence, the cells were washed three times using PBS. Ade-
noviral titers were determined and transient infections were 
carried out using an MOI of 100. After another 24-h culture 
in free-serum medium, the cells were collected or 5% CSE 
was added for culturing another 24 h, then the cells were 
harvested for Hoechst staining and Western blot analysis. 
1.7  Hoechst 33258 nuclear staining assay 
Nuclear staining with Hoechst 33258 (Sigma Chemical Co, 
USA) was performed as described elsewhere [23]. Briefly, 
the floating and trypsinized-adherent CSE treated and non- 
treated cells were collected at appropriate time points, 
washed with PBS and then fixed with 4% paraformaldehyde 
in PBS for 30 min at 4°C. After washing, the cells were 
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smeared onto microscope slides followed by incubation in 
Hoechst 33258 at a final concentration of 30 μg/mL at room 
temperature for 5 min. Nuclear morphology was then ex-
amined under a fluorescent microscope (Imaging Source 
Europe GmbH, Bremen, Germany). The analysis was per-
formed in duplicate by randomly counting more than 500 
nuclei from each concentration at a magnification of 100×. 
For each photomicrograph, a single observer who was blind 
to the related data performed the measurements.  
1.8  MTT assay 
The MTT assay was carried out as described previously 
[24]. Cells were plated in a 96-well plate at 1.3×104/well. 
After 24 h of plating, the cells were treated with 0, 2.5%, 
5%, 10%, 15% or 20% CSE for 24 h before MTT (20 μL of 
5 mg/mL) was added. The medium was removed from the 
wells 4 h after MTT addition, and 100 μL of dimethyl sul-
foxide was added to dissolve the formazan crystals before 
the absorbance was measured at 570 nm in an enzyme- 
linked immunosorbent assay reader. 
1.9  Western blotting analysis 
Nuclear and cytoplasmic extracts were prepared according 
to the method of Schreiber et al. [25]. Briefly, lung ho-
mogenate or the cell pellet was resuspended in 400 μL of 
cold buffer A (10 mmol L–1 HEPES pH 7.9, 10 mmol L–1 
KCl, 0.1 mmol L–1 EDTA, 0.1 mmol L–1 EGTA, 1 mmol 
L–1 DTT, 0.5 mmol L–1 PMSF). The cells were allowed to 
swell on ice for 15 min, after which 25 μL of a 10% solu-
tion of NP-40 was added and the tube was vigorously vor-
texed for 10 s. The homogenate was centrifuged for 30 s in 
a microcentrifuge and the supernatant containing the cyto-
plasmic extract was removed. The nuclear pellet was resus-
pended in 50 μL of ice-cold buffer B (20 mmol L–1 HEPES 
pH 7.9, 0.4 mol L–1 NaCl, 1 mmol L–1 EDTA, 1 mmol L–1 
EGTA, 1 mmol L–1 DTT, 1 mmol L–1 PMSF) and the tube 
was vigorously rocked at 4°C for 15 min on a shaking plat-
form. The nuclear extract was centrifuged for 5 min in a 
microcentrifuge at 4°C and the supernatant was frozen in 
aliquots at –80°C. The protein contents of the different frac-
tions were determined by the Bradford assay method. 
Proteins from the subcellular fractions were mixed with 
2×SDS sample buffer (100 mmol L–1 Tris-HCl (pH6.8), 4% 
SDS (w/v), 20% glycerol, 200 mmol L–1 DTT, 0.1% bromo-
phenol blue (w/v)) and boiled in a water bath for 5 min, be-
fore separation on 10% polyacrylamide gels and transfer to a 
polyvinylidene difluoride membrane (Millipore, Bedford, 
MA, USA). The membrane was then blocked in blocking 
buffer at room temperature for 6 h, incubated for 2 h at 25°C 
with primary antibody (mouse anti-AP-2α monoclonal anti-
body (Santa Cruz, US; 1:1000); mouse anti-caspase-3 mono-
clonal antibody (Beyotime Institute of Biotechnology, China;  
1:250); mouse anti-proliferating cellular nuclear antigen 
(PCNA) monoclonal antibody (Upstate, US; 1:1000)), fol-
lowed by horseradish peroxidase-conjugated secondary anti-
body IgG (Jackson Biotech, US; 1:1000), for 1 h at 25°C. 
Proteins were visualized using enhanced chemiluminiscence 
reagent (Amersham Pharmacia Biotech, UK) and X-ray film. 
1.10  Statistical analysis 
Data were presented as means ± SEM. Significance of dif-
ferences between groups was determined using ANOVA 
with two-tailed Student’s t test or LSD test. Multiple rate 
comparisons were examined by the χ2 test. P<0.05 was con-
sidered significant.  
2  Results 
2.1  Establishment of a rat model of COPD and the  
expression of AP-2α in lung tissue of COPD rats 
(i) Histological studies.  HE staining of lung tissue sections 
from the COPD group showed histologically advanced em-
physema. In contrast, histological markers of emphysema 
were absent in lung tissue sections obtained from the nor-
mal group (Figure 1). The MLI and DI in the COPD group 
(77±29 mm and 59%±7%, respectively) were significantly 
higher than those in the normal group (44±7 mm and 
18%±5%). There was increased inflammatory cell infiltration 
in COPD rat lungs compared with normal rat lungs, as as-
sessed by light microscopic examination of HE-stained slides. 
(ii) Lung function.  FEV0.3/FVC and PEF were lower in 
the COPD group (65.1%±8.4% and 18.8±1.6 mL/s, respec-
tively) compared with the normal group (85.6%±5.9% and 
47.2±7.3 mL/s) (P<0.05). 
(iii) Expression of AP-2α in lung tissue of COPD rats.  
AP-2α protein expression in lung nuclear extracts from rats 
in the two experimental groups was assessed by Western 
blotting. The expression of AP-2α was increased in the 
COPD group compared with the normal group (Figure 2).  
2.2  Cell proliferation, apoptosis and activation of  
caspase-3 in ECV304 cells treated with CSE 
To assay the cytotoxic potential of CSE, the influence of 
different concentrations of CSE on the viability of ECV304 
cells was measured by MTT assay. Compared with the con-
trol group, proliferation was significantly increased in the 
2.5% CSE-treated group, while it decreased in a concentra-
tion-dependent manner in the remaining CSE-treated groups 
(P < 0.01) (Figure 3). 
To examine the cell apoptosis in response to CSE treat-
ment, both control and 5% CSE-treated cells were stained 
with the fluorescent Hoechst 33528 dye and visualized  
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Figure 1  HE staining of lung tissue sections from rats in the normal 
group (a) and the COPD group (b) (100×). 
under a fluorescence microscope. Figure 4 shows the 
Hoechst staining results for 5% CSE treated-ECV304 cells 
over 48 h. ECV304 cells at 0 h remained uniformly stained. 
At 12 h, the cells began to display apoptotic morphology, 
such as enucleation and apoptotic bodies. At 24 h, nuclear 
condensation and fragmentation were more apparent, with the 
chromatin condensed into lumps, exhibiting punctated mor-
phology typical of apoptotic cells. At 36 and 48 h, apoptotic  
events culminated in the formation of apoptotic bodies, seen 
as smaller intensly stained spots. Shrinkage of cells, DNA 
condensation and even some cell destruction were observed. 
The expression levels of activated caspase-3 were increased 
in ECV304 cells treated with 5% CSE in a time-dependent 
manner (Figure 5(a)). Compared with the untreated cells, cas-
pase-3 levels increased to 135% at 12 h, 244% at 18 h, 289% 
at 24 h and 323% at 36 h, respectively (Figure 5(b)).  
2.3  The expression of AP-2α was induced by 5% CSE 
in ECV304 
The expression of AP-2α protein in ECV304 cells treated with  
 
Figure 2  Western blot analysis of AP-2α protein expression in lung 
nuclear extracts. Lanes 1 and 2, normal group; lanes 3–8, COPD groups. 
HeLa cell nuclear extract was used as a positive control. 
 
Figure 3  ECV304 cells were treated with a concentration of 0, 2.5%, 5%, 
10%, 15% and 20% of CSE for 24 h, and the cell viability was quantified 
using the MTT assay. The absorbance for 0% CSE group (control group) 
was considered as 100%. The abscissa indicates different groups; The 
Y-axis indicates the ratio of treatment group A/Ctrl group A. *, P < 0.05 
compared with the control group. 
 
Figure 4  Nuclear staining of ECV304 cells with Hoechst 33258. Cells were treated with 5% CSE. (a) Untreated (control) ECV304 cells remained uni-
formly stained with round and unpunctuated nuclei; (b) 5% CSE at 12 h; (c) 5% CSE at 24 h; (d) 5% CSE at 36 h; (e) 5% CSE at 48 h. 5% CSE-treated 
ECV304 cells showed apoptotic morphology: cell shrinkage, DNA condensation and nuclear fragmentation.  
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Figure 5  The expression of activated caspase-3 was analyzed by Western 
blotting in ECV304 cells treated with 5% CSE for 0, 12, 18, 24 and 36 h, 
respectively. The nuclear and cytoplasmic fractions were isolated and the 
level of activated caspase-3 was assayed by Western blotting (a). β-actin was 
used as an internal control. (b) Compared with the control, the expressions of 
activated caspase-3 at 18, 24 and 36 h were significant (P < 0.001, n = 3). 
5% CSE was detected by Western blotting. The expression 
level of AP-2α increased in a time-dependent manner (Fig-
ure 6(a)), with levels increasing to 106% at 6 h, 125% at 12 
h, 139% at 24 h and 161% at 48 h, respectively, compared 
to untreated controls (Figure 6(b)). 
2.4  Overexpression of AP-2α by adenoviral infection  
inhibited both apoptosis and caspase-3 activation  
induced by CSE in ECV304 
(i) Expression of AP-2α in Ad-AP-2α-infected cells.  To  
 
Figure 6  The expression of AP-2α induced by 5% CSE. The cells were 
stimulated with 5% CSE for 0, 6, 12, 24 and 48 h. Nucleoproteins were 
isolated and the levels of AP-2α were assayed by Western blotting. HeLa 
cells were used as the positive control. PCNA was used as an internal con-
trol. (a) There was a time-dependent increase in the expression level of 
AP-2α; (b) compared with Ctrl (0% CSE), the expression levels of AP-2α 
at 12, 24 and 48 h were increased significantly (P < 0.05 for all, n = 3). 
detect the induced expression of AP-2α protein in Ad-AP- 
2α-infected ECV304 cells, AP-2α protein levels were 
monitored and compared to the levels in cells infected with 
the control virus Ad-BgII. At 24 h after infection, nuclear 
extracts were collected and the expression of AP-2α protein 
was assessed. Upon Ad-AP-2α infection, ECV304 cells 
showed twice the amount of AP-2α protein in comparison 
with Ad-BgII transfection (Figure 7(a)).  
(ii) AP-2α overexpression inhibited the apoptosis in-
duced by CSE in ECV304.  To study the effect of AP-2α 
on apoptosis induced by CSE, we stimulated ECV304 cells 
with 5% CSE 24 h after infection with Ad-BgII and 
Ad-AP-2α, before assessing the morphological changes 24 
h later. ECV304 cells infected with Ad-BgII displayed 
apoptotic morphology, such as enucleation and apoptotic 
bodies, whereas ECV304 infected with Ad-AP-2α showed 
fewer apoptotic cells than with Ad-Bg-II (P < 0.005, n = 3) 
(Figure 7(b)). 
(iii) AP-2α overexpression inhibited caspase-3 activation 
induced by CSE in ECV304.  To study the effect of AP-2α 
on the activation of caspase-3 induced by CSE, ECV304 
cells were treated as described in section (ii) before the pro-
tein level of activated caspase-3 (17 kD) was measured by 
Western blot (Figure 7(c)). Compared with the Ad-BgII 24 
h group, the expression of activated caspase-3 is signifi-
cantly decreased in the Ad-AP-2α group (P<0.001).  
 
Figure 7  The effect of AP-2α over-expression on CSE-induced apoptosis. 
(a) The induced expression of AP-2α protein in Ad-AP-2α-infected 
ECV304 cells. (b) Nuclear staining of ECV304 cells with Hoecsht 33258. 
ECV304 cells were infected with AP-2α (1) or Ad-BgII (2) for 24 h, and 
then stimulated with 5% CSE for 24 h. (c) Effect of AP-2α overexpression 
on the activation of caspase-3 (17 kD) induced by CSE in ECV304 cells. 
β-actin was used as an internal control. Lane 1, ECV304 cells were in-
fected with Ad-BgII for 24 h, and then treated with 5% CSE for 24 h; lane 
2, ECV304 cells were infected with Ad-AP-2α for 24 h, then treated with 
5% CSE for 24 h; lane 3, ECV304 cells were cultured with a serum-free 
medium for 24 h, and then treated with 5% CSE for 24 h.  
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3  Discussion 
COPD is characterized by chronic inflammation of the air-
ways and progressive destruction of lung parenchyma. Em-
physema is a major component of COPD and cigarette 
smoking is the single most important factor in the develop-
ment of emphysema. The present study showed that expo-
sure of rats to cigarette smoke decreased their FEV0.3/FVC 
and PEF, consistent with the clinical observations in COPD 
patients. There were obvious emphysematous changes in the 
COPD group, including enlargement of alveolar spaces and 
destruction of alveolar walls, which were quantified by 
measuring MLI and DI, respectively. MLI and DI were in-
creased in the lungs of rats in the COPD group compared 
with those in the normal group. These results suggest that a 
rat model of COPD was successfully established. 
Recently, an increasing body of evidence suggests that 
apoptosis of structural cells in the lung might be an impor-
tant upstream event in the pathogenesis of COPD. There is 
an increase in the number of apoptotic cells in the lungs of 
COPD patients. Because this is not counterbalanced by an 
increase in proliferation of these structural cells, the net 
result is destruction of lung tissue and the development of 
emphysema.  
Increasing evidence demonstrates that AP-2α is involved 
in apoptosis. In some tissues the expression of AP-2α is 
decreased or lost resulting in apoptosis increase. In addition, 
AP-2α functions as an anti-apoptotic factor in epithelial 
ovarian cancer [26], colorectal adenomas and adenocarci-
nomas [27], human gliomas [28], prostate cancer cells [29] 
and melanoma [30]. In contrast, AP-2α expression is in-
creased and functions as a pro-apoptotic factor in human 
failing myocardium with idiopathic-dilated cardiomyopathy 
and in human breast cancer [31]. We show that AP-2α pro-
tein was expressed and increased in the lung of a rat model 
of COPD induced by cigarette smoke exposure, and was 
associated with increased cell apoptosis. It is unclear 
whether there was a direct relationship between the increase 
in AP-2α and the increase in cell apoptosis. 
Lung alveolar walls cells includes epithelial cells, endo-
thelial cells and interstitial cells. Taraseviciene-Stewart et al. 
[32] developed a model of autoimmune emphysema in adult 
rats by intraperitoneal injection of human umbilical vein 
endothelial cells (HUVECs). In this model, anti-VEGF re-
ceptor antibodies were generated and apoptosis, especially 
of endothelial cells, occured in the lung. This suggests the 
importance of endothelial cell apoptosis in COPD.  
The ECV304 cell line, although identified as a bladder 
carcinoma cell line, displays some endothelial characteris-
tics including tubule formation (differentiation) following 
appropriate stimulation [33,34]. We used ECV304 cells to 
study the role and mechanisms of AP-2α in vascular endo-
thelial cell apoptosis induced by cigarette smoke exposure. 
Compared with the control group, proliferation was signifi-
cantly increased in cells treated with 2.5% CSE, while it 
decreased in a dose-dependent manner at concentrations 
higher than 2.5%. Apoptosis was also increased in a 
time-dependant manner in cells exposed to 5% CSE. At 
higher concentrations of CSE (15%–20%) necrosis was 
evident. The increased proliferation at low concentration or 
short-period exposure to CSE may be because the low lev-
els of damaging factors present were unable to induce apop-
tosis but could induce oncogenic mutation. This may be one 
reason why lung cancer is prone to occur in smokers. 
Higher CSE concentration or longer periods of stimulation 
with CSE leads to apoptosis or even necrosis, consistent 
with the results from other researchers [35,36]. Besides 
treatment factors, cell type [37] is also one factor that can 
affect cell apoptosis or necrosis when stimulated. 
The expressions of cleaved caspase-3 and AP-2α in 
ECV304 cells were increased in a time-dependent manner 
following 5% CSE treatment. The activation of caspase-3 is 
considered an important index of cell apoptosis. To probe 
the relationship between the expression of AP-2α and the 
activation of caspase-3, we successfully infected ECV304 
cells with Ad-AP-2α. As the results show, over-expression 
of AP-2α inhibited ECV304 cell apoptosis and caspase-3 
activation induced by CSE. This suggests that AP-2α might 
protect ECV304 cells from CSE. There is no report showing 
that AP-2α directly modulates the expression, activation or 
cleavage of caspase-3. Possible mechanisms for AP-2α in-
hibition of apoptosis include inhibiting the expression of 
Mn-SOD [38], down-regulating the expression and inhibit-
ting the activation of MMP-9 [39], negative regulation of 
c-MYC activity [40] activating some oncogene such as 
HER-2/neu [31] and interfering with the cytokine network 
[41]. 
This is the first report to demonstrate that the expression 
of AP-2α is increased in lung tissue of COPD rats and 
ECV304 cells stimulated by cigarette smoke exposure. 
Adenoviral-mediated over-expression of AP-2α protects 
against ECV304 cell apoptosis and caspase-3 activation 
induced by CSE. These results suggest that AP-2α might 
protect endothelial cells against CSE and rat lung tissue 
against cigarette smoke exposure. Knocking out the AP-2α 
gene in rats would confirm these observations. 
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